--- title: "XLDZ issued a profit warning, expecting a net profit attributable to the parent company of 166 million to 198 million yuan in the first half of the year, turning losses into profits" type: "News" locale: "en" url: "https://longbridge.com/en/news/247788025.md" description: "XLDZ expects a net profit attributable to the parent company of 166 million to 198 million yuan in the first half of 2025, achieving a turnaround from loss to profit. The net profit after deducting non-recurring gains and losses is expected to be 71 million to 87 million yuan, mainly benefiting from the increase in investment income from financial products and the gains from changes in the fair value of trading financial assets" datetime: "2025-07-09T09:40:03.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/247788025.md) - [en](https://longbridge.com/en/news/247788025.md) - [zh-HK](https://longbridge.com/zh-HK/news/247788025.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/247788025.md) | [繁體中文](https://longbridge.com/zh-HK/news/247788025.md) # XLDZ issued a profit warning, expecting a net profit attributable to the parent company of 166 million to 198 million yuan in the first half of the year, turning losses into profits According to the Zhitong Finance APP, XLDZ (002546.SZ) disclosed its performance forecast for the first half of 2025, expecting a net profit attributable to shareholders of the listed company to be between 166 million yuan and 198 million yuan, turning a profit; the net profit after deducting non-recurring gains and losses is expected to be between 71 million yuan and 87 million yuan. The non-recurring income for this period has significantly increased compared to the same period last year, due to increased investment income from the company's financial products and increased fair value changes of held trading financial assets ### Related Stocks - [xldz (002546.CN)](https://longbridge.com/en/quote/002546.CN.md) ## Related News & Research - [08:15 ETDictionary.com's 2026 Winter Word Drop Embraces Innovation, Goes Global and Enters the Chat](https://longbridge.com/en/news/277470747.md) - [08:03 ETDecentralized Clinical Trial Validates Novel "Fasting Mimetic" Formulation for Cardiometabolic Health](https://longbridge.com/en/news/277468910.md) - [LibreOffice Online dragged out of the attic, dusted off for another go](https://longbridge.com/en/news/277439337.md) - [Vial Doses First Patient for Phase 1 Trial of Vial’s IL-13 x TSLP, a Novel Bispecific Antibody](https://longbridge.com/en/news/277585325.md) - [Think In Italian Unveils Free Preview of SpeakTwice Italian App](https://longbridge.com/en/news/277506153.md)